TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
DGX

Quest Diagnostics Incorporated

Healthcare · Diagnostics & Research

236.30$ -0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow DGX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12.6% 10.8% 14.2% 15.2% 15.9% 16.1% 21.2% 20.7% 17.4% 13.7% 13.5% 17.1%
4.2% 4.1% 3.3% 3.5% 4.1% 4.3% 3.8% 3.8% 4.4% 4.7% 5.0% 5.2%
0.7% 0.7% 0.9% 1.0% 0.8% 0.7% 1.0% 0.7% 0.8% 0.8% 0.9% 0.8%
4.8% 1.7% 3.9% 5.1% 2.0% -0.3% 1.3% -2.4% 1.5% – – –
-4.4% -5.0% -2.2% -4.1% -0.7% 0.5% 0.2% 0.8% 1.2% -1.6% -2.0% 0.5%
4.1% 3.5% 3.9% 3.3% 5.1% 5.2% 4.4% 3.7% 4.1% 4.4% 4.3% 4.8%
-13.8% -4.8% -2.0% -10.4% -10.6% -5.3% -8.2% 0.2% -5.5% -11.5% -25.8% -5.7%
2.5% 2.8% 3.0% 3.2% 3.5% 3.7% 3.1% 2.9% 3.1% 3.4% 3.4% 3.2%
-1.8% -3.0% -7.9% -6.0% -4.3% -4.6% -3.4% -20.4% -14.2% -3.0% -1.5% -4.1%
5.0% -1.1% 1.9% 0.3% 1.6% 10.8% -8.5% 0.0% 0.0% 8.1% 15.6% -5.5%
1.2% -6.8% -9.2% -7.7% -5.3% 2.9% -13.4% -23.5% -17.5% 1.7% 11.0% -12.6%
0.1% -0.8% 3.0% -2.9% 0.0% 13.7% -0.4% -2.7% -5.6% 4.0% -1.4% -1.2%
8.5% 7.3% 10.3% 12.0% 10.8% 10.9% 16.8% 17.0% 13.3% 9.3% 9.2% 12.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?